USE OF OBG3 FOR PROMOTING CENTRAL NERVOUS SYSTEM REMYELINATION

Details for Australian Patent Application No. 2002339699 (hide)

Owner GENSET S.A.

Inventors LUCAS, John

Pub. Number AU-A-2002339699

PCT Number PCT/IB02/04924

PCT Pub. Number WO2003/044057

Priority 60/332,119 21.11.01 US

Filing date 29 October 2002

Wipo publication date 10 June 2003

International Classifications

C07K 014/705 Peptides having more than 20 amino acids

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/332,119 21.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002339699

5 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002339700-Animal consumable labeling and method thereof

2002339698-Biallelic markers of D-amino acid oxidase and uses thereof